Stock MTST METASTAT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News MetaStat, Inc.

Equities

MTST

US59140A2033

Market Closed - OTC Markets
Other stock markets
 01:47:00 2023-07-27 pm EDT 		5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for MetaStat, Inc. -.--% -.--%
2018 MetaStat, Inc. Presents Positive Data Showing Inhibition of the MENA-Pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer CI
2017 MetaStat, Inc. Appoints Renato T. Skerlj as Member of its Scientific and Clinical Advisory Board CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MetaStat, Inc. Presents Positive Data Showing Inhibition of the MENA-Pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer
CI
MetaStat, Inc. Appoints Renato T. Skerlj as Member of its Scientific and Clinical Advisory Board
CI
MetaStat, Inc. announced that it has received $2.57 million in funding
CI
MetaStat, Inc. announced that it expects to receive $7 million in funding
CI
MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene Corporation
CI
MetaStat, Inc. Appoints Paul Billings to its Board of Directors, Effective as of May 24, 2017
CI
MetaStat, Inc. Announces Management Changes
CI
MetaStat, Inc. Announces Board Changes
CI
MetaStat, Inc. Announces Resignation of Martin J. Driscoll from the Board of Directors
CI
MetaStat, Inc. Presents Supportive Data for the Role of Mena Protein Isoforms in Tumor Dissemination at the 2017 American Association of Cancer Research Annual Meeting
CI
MetaStat, Inc. Receives Additional State Clinical Laboratory Licenses
CI
MetaStat, Inc. Presents Positive Data from Two Clinical Studies of Metasite Breast at 2016 San Antonio Breast Cancer Symposium
CI
MetaStat, Inc. announced that it has received $2.61 million in funding
CI
MetaStat, Inc. cancelled the transaction announced on October 10, 2014
CI
MetaStat, Inc. and Celgene Corporation Enter into Amendment to Pilot Materials Transfer Agreement
CI
MetaStat, Inc. Announces Resignation of Johan M. Spoor as Board of Directors
CI
MetaStat, Inc. announced that it expects to receive $20 million in funding
CI
MetaStat, Inc. announced that it has received $0.5 million in funding
CI
MetaStat, Inc. announced that it expects to receive $5 million in funding
CI
MetaStat, Inc. Names Jerome B. Zeldis as Vice Chairman of the Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MTST Stock
  4. News MetaStat, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW